Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic dysfunction-associated steatohepatitis to a market that could reach $16 billion by ...

Colossal, a genetics startup, has birthed three pups that contain ancient DNA retrieved from the remains of the animal’s ...

In recent years, stem cells and epidermal growth factors have become key ingredients in skincare formulations. Some brands ...